Global Needle-Free Drug Delivery Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Needle-Free Drug Delivery Revenue
• 1.4 Market by Type
  • 1.4.1 Global Needle-Free Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Jet-based
  • 1.4.3 Spring-based
  • 1.4.4 Laser-based
• 1.5 Market by Application
  • 1.5.1 Global Needle-Free Drug Delivery Market Share by Application: 2020 VS 2026
  • 1.5.2 Insulin delivery
  • 1.5.3 Vaccination
  • 1.5.4 Pain management
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Needle-Free Drug Delivery Market Perspective (2015-2026)
• 2.2 Global Needle-Free Drug Delivery Growth Trends by Regions
  • 2.2.1 Needle-Free Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Needle-Free Drug Delivery Historic Market Share by Regions (2015-2020)
  • 2.2.3 Needle-Free Drug Delivery Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Needle-Free Drug Delivery Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Needle-Free Drug Delivery Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Needle-Free Drug Delivery Players by Market Size
  • 3.1.1 Global Top Needle-Free Drug Delivery Players by Revenue (2015-2020)
  • 3.1.2 Global Needle-Free Drug Delivery Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Needle-Free Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Needle-Free Drug Delivery Market Concentration Ratio
  • 3.2.1 Global Needle-Free Drug Delivery Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Needle-Free Drug Delivery Revenue in 2019
• 3.3 Needle-Free Drug Delivery Key Players Head office and Area Served
• 3.4 Key Players Needle-Free Drug Delivery Product Solution and Service
• 3.5 Date of Enter into Needle-Free Drug Delivery Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Needle-Free Drug Delivery Historic Market Size by Type (2015-2020)
• 4.2 Global Needle-Free Drug Delivery Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Needle-Free Drug Delivery Market Size by Application (2015-2020)
• 5.2 Global Needle-Free Drug Delivery Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Needle-Free Drug Delivery Market Size (2015-2020)
• 6.2 Needle-Free Drug Delivery Key Players in North America (2019-2020)
• 6.3 North America Needle-Free Drug Delivery Market Size by Type (2015-2020)
• 6.4 North America Needle-Free Drug Delivery Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Needle-Free Drug Delivery Market Size (2015-2020)
• 7.2 Needle-Free Drug Delivery Key Players in Europe (2019-2020)
• 7.3 Europe Needle-Free Drug Delivery Market Size by Type (2015-2020)
• 7.4 Europe Needle-Free Drug Delivery Market Size by Application (2015-2020)

8 China

• 8.1 China Needle-Free Drug Delivery Market Size (2015-2020)
• 8.2 Needle-Free Drug Delivery Key Players in China (2019-2020)
• 8.3 China Needle-Free Drug Delivery Market Size by Type (2015-2020)
• 8.4 China Needle-Free Drug Delivery Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Needle-Free Drug Delivery Market Size (2015-2020)
• 9.2 Needle-Free Drug Delivery Key Players in Japan (2019-2020)
• 9.3 Japan Needle-Free Drug Delivery Market Size by Type (2015-2020)
• 9.4 Japan Needle-Free Drug Delivery Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Needle-Free Drug Delivery Market Size (2015-2020)
• 10.2 Needle-Free Drug Delivery Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Needle-Free Drug Delivery Market Size by Type (2015-2020)
• 10.4 Southeast Asia Needle-Free Drug Delivery Market Size by Application (2015-2020)

11 India

• 11.1 India Needle-Free Drug Delivery Market Size (2015-2020)
• 11.2 Needle-Free Drug Delivery Key Players in India (2019-2020)
• 11.3 India Needle-Free Drug Delivery Market Size by Type (2015-2020)
• 11.4 India Needle-Free Drug Delivery Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Needle-Free Drug Delivery Market Size (2015-2020)
• 12.2 Needle-Free Drug Delivery Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Needle-Free Drug Delivery Market Size by Type (2015-2020)
• 12.4 Central & South America Needle-Free Drug Delivery Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Antares Pharma
  • 13.1.1 Antares Pharma Company Details
  • 13.1.2 Antares Pharma Business Overview
  • 13.1.3 Antares Pharma Needle-Free Drug Delivery Introduction
  • 13.1.4 Antares Pharma Revenue in Needle-Free Drug Delivery Business (2015-2020))
  • 13.1.5 Antares Pharma Recent Development
• 13.2 Pharmajet
  • 13.2.1 Pharmajet Company Details
  • 13.2.2 Pharmajet Business Overview
  • 13.2.3 Pharmajet Needle-Free Drug Delivery Introduction
  • 13.2.4 Pharmajet Revenue in Needle-Free Drug Delivery Business (2015-2020)
  • 13.2.5 Pharmajet Recent Development
• 13.3 Optinose
  • 13.3.1 Optinose Company Details
  • 13.3.2 Optinose Business Overview
  • 13.3.3 Optinose Needle-Free Drug Delivery Introduction
  • 13.3.4 Optinose Revenue in Needle-Free Drug Delivery Business (2015-2020)
  • 13.3.5 Optinose Recent Development
• 13.4 Valeritas
  • 13.4.1 Valeritas Company Details
  • 13.4.2 Valeritas Business Overview
  • 13.4.3 Valeritas Needle-Free Drug Delivery Introduction
  • 13.4.4 Valeritas Revenue in Needle-Free Drug Delivery Business (2015-2020)
  • 13.4.5 Valeritas Recent Development
• 13.5 Crossject
  • 13.5.1 Crossject Company Details
  • 13.5.2 Crossject Business Overview
  • 13.5.3 Crossject Needle-Free Drug Delivery Introduction
  • 13.5.4 Crossject Revenue in Needle-Free Drug Delivery Business (2015-2020)
  • 13.5.5 Crossject Recent Development
• 13.6 Injex Pharma
  • 13.6.1 Injex Pharma Company Details
  • 13.6.2 Injex Pharma Business Overview
  • 13.6.3 Injex Pharma Needle-Free Drug Delivery Introduction
  • 13.6.4 Injex Pharma Revenue in Needle-Free Drug Delivery Business (2015-2020)
  • 13.6.5 Injex Pharma Recent Development
• 13.7 3M Pharmaceuticals
  • 13.7.1 3M Pharmaceuticals Company Details
  • 13.7.2 3M Pharmaceuticals Business Overview
  • 13.7.3 3M Pharmaceuticals Needle-Free Drug Delivery Introduction
  • 13.7.4 3M Pharmaceuticals Revenue in Needle-Free Drug Delivery Business (2015-2020)
  • 13.7.5 3M Pharmaceuticals Recent Development
• 13.8 Becton Dickinson (BD)
  • 13.8.1 Becton Dickinson (BD) Company Details
  • 13.8.2 Becton Dickinson (BD) Business Overview
  • 13.8.3 Becton Dickinson (BD) Needle-Free Drug Delivery Introduction
  • 13.8.4 Becton Dickinson (BD) Revenue in Needle-Free Drug Delivery Business (2015-2020)
  • 13.8.5 Becton Dickinson (BD) Recent Development
• 13.9 MedImmune
  • 13.9.1 MedImmune Company Details
  • 13.9.2 MedImmune Business Overview
  • 13.9.3 MedImmune Needle-Free Drug Delivery Introduction
  • 13.9.4 MedImmune Revenue in Needle-Free Drug Delivery Business (2015-2020)
  • 13.9.5 MedImmune Recent Development
• 13.10 Mystic Pharmaceuticals
  • 13.10.1 Mystic Pharmaceuticals Company Details
  • 13.10.2 Mystic Pharmaceuticals Business Overview
  • 13.10.3 Mystic Pharmaceuticals Needle-Free Drug Delivery Introduction
  • 13.10.4 Mystic Pharmaceuticals Revenue in Needle-Free Drug Delivery Business (2015-2020)
  • 13.10.5 Mystic Pharmaceuticals Recent Development
• 13.11 Zogenix
  • 10.11.1 Zogenix Company Details
  • 10.11.2 Zogenix Business Overview
  • 10.11.3 Zogenix Needle-Free Drug Delivery Introduction
  • 10.11.4 Zogenix Revenue in Needle-Free Drug Delivery Business (2015-2020)
  • 10.11.5 Zogenix Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer